Ekaterina Heldwein: Crystallizing killers

By Jennifer Welsh Ekaterina Heldwein: Crystallizing killers © Jessica Scranton Assistant Professor of Molecular Biology and Microbiology, Tufts University. Age: 37 Structural virologist Ekaterina Heldwein, who goes by Katya, has followed a less-than-direct path to success in science. As a Russian chemistry undergraduate with a desire to live abroad but little money, she headed to the biochemistry graduate program at Oregon Health Sciences University

Written byJennifer Welsh
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

Assistant Professor of Molecular Biology and Microbiology, Tufts University. Age: 37

Structural virologist Ekaterina Heldwein, who goes by Katya, has followed a less-than-direct path to success in science. As a Russian chemistry undergraduate with a desire to live abroad but little money, she headed to the biochemistry graduate program at Oregon Health Sciences University (OHSU) in 1994. But she had to find it first.

“I was only worried she could find Portland,” said her graduate advisor, OHSU structural biologist Richard Brennan. While planning her trip, Heldwein had accidently bought a ticket to Portland, Maine, and didn’t notice her mistake until right before she boarded the plane in New York. While Heldwein was stranded at the airport, an OHSU graduate student was able to rearrange a corrected flight for her.

Structure Made Simple

Freeze Frame

Structural Hints at Ebola’s Cunning

Elusive Envelope Glycoproteins

METHODS: Having found Oregon, Heldwein was thrilled to ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies